Salazar GDM, Guerrero MAL, Flores ALP

Language: Spanish
References: 23
Page: 106-110
PDF size: 212.56 Kb.

ABSTRACT

Objective: to analyze the seasonal profile of allergic rhinitis in adult patients aged 20 to 59 years. Methods: cross-sectional analytical study conducted at the Family Medicine Unit No. 75 of the Mexican Institute of Social Security, 182 patients with allergic rhinitis (AR) were included, by simple random probability sampling. Two questionnaires were applied; the first, based on the Seasonal Pattern Assessment Questionnaire (SPAQ) adapted for allergic rhinitis which describes symptomatology characteristics and limitation of daily activities; the second consisted of the Allergic Rhinitis and its Impact on Asthma (ARIA) for the determination of duration and severity. The inferential statistical analysis was obtained by χ², with a significance level of p‹0.05 and a 95% interval. Results: peak months in symptomatology were observed, which corresponded to April (17.58%), November (26.92%) and December (38.46%), there was persistent duration in 26.4% of cases and mild severity in 36.8% of adults with ar; when applying the χ² test between the months with the highest peak in symptomatology and aria, p›0.05 value was obtained. Conclusions: seasonal profile and allergic rhinitis present two peaks, its symptomatology increases in spring and winter, it was determined by aria that there was an important fraction of cases with persistent duration and mild severity. Preventive measures are required for medical control and improvement in quality of life.

REFERENCES

1. Sakano E, Sarinho E, Cruz A, Pastorino A, Tamashiro E, Kuschnir F, et al. Brazilian consensus on rhinitis an update on allergic rhinitis. Braz J otorhinolaryngol. 2018;84(1):3-14.

2. Vandenplas I, Vinnikov D, Blanc P, Agache I, Bachert C, Bewick M, et al. Impact of rhinitis on work productivity: a systematic review. J allergy clin Immunol pract. 2018;6(4):1274-1286.

3. Small P, Keith P, Kim H. Allergic rhinitis. Allergy Asthma Clin Immunol. 2018;14(2):31-41.

4. Tan R, Cvetkovski B, Kritikos V, Price D, Yan K, Smith P, et al. The burden of rhinitis and the impact of medication management within the community pharmacy setting. J allergy clin Immunol prac. 2018;5(6):1717-1724.

5. Dykewics M, Wallace D, Baroody F, Bernstein J, Craig T, Finegold I, et al. Treatment of seasonal allergic rhinitis. Ann allergy asthma Immunol. 2017; 119(6):489-511.

6. Patel N, Prizment A, Thyagarajan B, Roberts E, Nelson H, Church T, et al. Urban vs rural residency and allergy prevalence among adult women. Ann allergy asthma Immunol. 2018;120(6):654-660.

7. Hsu D, Suh J. Rhinitis and sinusitis in the geriatric population. Otolaryngol clin. 2018; 51(4):803-813.

8. Shtraks J, Toskala E. Manifestations of inhalant allergies beyond the nose. Otolaryngol clin. 2017;50(6):1051-1064.

9. López B, Torres J, Álvarez M, Guerrero A, Suarez M, García C, et al. Behavior of allergy rhinitis in old Havana. March to December 2016. J allergy clin Immunol. 2016;141(2):127-128.

10. Bousquet J, Hellings P, Agache I, Amat F, Annesi- Maesano I, Ansotegui I, et al. Allergic rhinitis and its impact on asthma (ARIA) phase 4 2018: change mobile technology. J allergy clin Immunol. 2019;143(3):864-879.

11. Goikolea J, Miralles G, Bulbena A, Vieta E, Bulbena Cabré A. Adaptación española del cuestionario de evaluación de perfil estacional (Seasonal Pattern Assessment Questionnaire, SPAQ) en las versiones de adultos e infanto-juvenil. Actas esp psquiatr. 2003;31(4):192-198.

12. Brozek J, et al. Pautas sobre rhinitis alérgica y su impacto en el asma (ARIA): revisión de 2016. The journal of allergy and clinical immunology. 2017;140(4):950-958.

13. Zhu R, et al. The allergic rhinitis control test questionnaire is valuable in guiding step-down pharmacotherapy treatment of allergic rhinitis. J Allergy clin immunol. 2018;7(1):272-273.

14. Pinart M, et al. Sex-related allergic rhinitis prevalence switch from childhood to adulthood: A systematic review and meta-analysis. Int Arch Allergy Immunol. 2017;172(4):224-235.

15. Nishijima H, Suzuki S, Kondo K, Yamasoba T, Yanagimoto S. Environmental factors associated with allergic rhinitis symptoms in Japanese university students: a cross-sectional study. Aurin nasus laringee. 2018;45(5):1006-113.

16. Martorano L, Erwin E. Aeroallergen exposure and spread in the modern era. Rev J allergy clin immunol pract. 2018;6(6):1835-1842.

17. Maio S, Baldacci S, Carrozzi L, Pistelli F, Simoni M, Angino A, et al. 18 years cumulative incidence of respiratory/allergic symptoms/diseases and risk factors in the pisa epidemiological study. Respiratory medicine. 2019;158:33-41.

18. Arsoy G, Varis A, Saloumi L, Abdi A, Basgut B. Insights on allergic rhinitis management from a northem cyprus perspective and evaluation of the impact of pharmacist led educational intervention on patients outcomes. J med. 2018:54(83):54-83.

19. Cingui C, Muluk N, Scadding G. Will every child have allergic rhinitis soon? International J of pediatric otorhinolaryngology. 2019;118:53-58.

20. Klimek L, Bergmann K, Bierdermann T, Bousquet J, Hellings P, Jung K. Visual analogue scales (VAS): measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care. Allergo J int. 2017;26(8):16-24.

21. Stuart L. Reducing environmental allergic trigger: policy issues. J Allergy clin Immunol pract. 2018;6(1):32-35.

22. Cecchi L, D´Amato G, Annesi-Maesano I. External exposome and allergic respiratory and skin diseases. J allergy clin immunol. 2018;141(3):846-857.

23. Mariño F, Valls-Mateus M, Haag O, Alobid I, Bousquet J, Mullol J. Smell loss is associated with severe and uncontrolled disease in children and adolescents with persistent allergic rhinitis. Clinical communications. 2018;5(6):1752-1755.